LGN Files First Antitrust Class Action Against GoodRx and Pharmacy Benefit Managers

On October 30, LGN, along with co-counsel at Pearson Warshaw LLP, filed an antitrust class action lawsuit against generic drug coupon provider GoodRx and Pharmacy Benefit Managers (PBMs) Caremark, Express Scripts, MedImpact, and Navitus. The lawsuit is brought by the plaintiff, Keaveny Drug, an independent pharmacy in Minnesota. The lawsuit alleges that the defendants (GoodRx and the PBMs) conspired to suppress reimbursement rates and increase fees charged to independent pharmacies on all GoodRx-related transactions through GoodRx’s “integrated savings program.”

The lawsuit seeks to recover the damages incurred by independent pharmacies throughout the United States, and to put a stop to the illegal conduct of GoodRx and the PBMs in participating in the GoodRx integrated savings program. It is the first lawsuit in the U.S. challenging this conduct.

Click below for more information.